A multi‐institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1‐2N1 breast cancer
Open Access
Abstract
Background: Post‐mastectomy radiation therapy (PMRT) in women with pathologic stage T1‐2N1M0 breast cancer is controversial.Methods: Data from five North American institutions including women undergoing mastectomy without neoadjuvant therapy with pT1‐2N1M0 breast cancer treated from 2006 to 2015 were pooled for analysis. Competing‐risks regression was performed to identify factors associated with locoregional recurrence (LRR), distant metastasis (DM), overall recurrence (OR), and breast cancer mortality (BCM).Results: A total of 3532 patients were included for analysis with a median follow‐up time among survivors of 6.8 years (interquartile range [IQR], 4.5–9.5 years). The 2154 (61%) patients who received PMRT had significantly more adverse risk factors than those patients not receiving PMRT: younger age, larger tumors, more positive lymph nodes, lymphovascular invasion, extracapsular extension, and positive margins (p < .05 for all). On competing risk regression analysis, receipt of PMRT was significantly associated with a decreased risk of LRR (hazard ratio [HR], 0.21; 95% confidence interval [CI], 0.14–0.31; p < .001) and OR (HR, 0.76; 95% CI, 0.62–0.94; p = .011). Model performance metrics for each end point showed good discrimination and calibration. An online prediction model to estimate predicted risks for each outcome based on individual patient and tumor characteristics was created from the model.Conclusions: In a large multi‐institutional cohort of patients, PMRT for T1‐2N1 breast cancer was associated with a significant reduction in locoregional and overall recurrence after accounting for known prognostic factors. An online calculator was developed to aid in personalized decision‐making regarding PMRT in this population.Keywords
This publication has 23 references indexed in Scilit:
- Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trialsThe Lancet, 2014
- Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast CancerNew England Journal of Medicine, 2013
- Impact of Postmastectomy Radiation on Locoregional Recurrence in Breast Cancer Patients With 1-3 Positive Lymph Nodes Treated With Modern Systemic TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelinesBMC Medical Research Methodology, 2009
- Elucidating the Role of Chest Wall Irradiation in ‘Intermediate-risk’ Breast Cancer: the MRC/EORTC SUPREMO TrialClinical Oncology, 2008
- Study of Failure Pattern Among High-Risk Breast Cancer Patients With or Without Postmastectomy Radiotherapy in Addition to Adjuvant Systemic Therapy: Long-Term Results From the Danish Breast Cancer Cooperative Group DBCG 82 b and c Randomized StudiesJournal of Clinical Oncology, 2006
- Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized TrialJNCI: Journal of the National Cancer Institute, 2005
- Multiple Imputation after 18+ YearsJournal of the American Statistical Association, 1996
- A Leisurely Look at the Bootstrap, the Jackknife, and Cross-ValidationThe American Statistician, 1983